Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? ADVENTRX Pharmaceuticals, Inc.
ADVENTRX Pharmaceuticals shares gained 25 percent on nearly 3 million shares traded Wednesday, which was almost ten-times the average daily volume. The company has initiated patient recruitment in its pivotal phase 3 clinical study of ANX-188 in sickle cell disease.
Going forward ... (see research report)
Subscribe to News Feeds